NANOBIOTIX : Article ! Tout va tres bien !

flaire75

04 févr. 2024 •08:22

Nanobiotix S.A. (NASDAQ:NBTX - Get Free Report) shares fell 2.3% during trading on Friday . The stock traded as low as $7.13 and last traded at $7.35. 23,972 shares changed hands during mid-day trading, an increase of 33% from the average session volume of 18,007 shares. The stock had previously closed at $7.52.

Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on NBTX. SVB Leerink began coverage on Nanobiotix in a report on Friday, December 8th. They issued an "outperform" rating and a $11.00 price objective for the company. Leerink Partnrs reissued an "outperform" rating on shares of Nanobiotix in a report on Friday, December 8th.

View Our Latest Analysis on NBTX

Nanobiotix Price Performance
The business has a 50-day moving average price of $6.92 and a 200-day moving average price of $7.47.

Institutional Investors Weigh In On Nanobiotix
An institutional investor recently bought a new position in Nanobiotix stock. Johnson & Johnson acquired a new position in Nanobiotix S.A. (NASDAQ:NBTX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 959,637 shares of the company's stock, valued at approximately $8,397,000. Nanobiotix accounts for 3.1% of Johnson & Johnson's portfolio, making the stock its 9th largest holding. Johnson & Johnson owned approximately 2.65% of Nanobiotix at the end of the most recent quarter. 9.93% of the stock is currently owned by hedge funds and other institutional investors.